Archive for the ‘wiley retractions’ Category
A food science journal has retracted a paper over “a breach of reviewer confidentiality,” after editors learned it contained text from an unpublished manuscript — which one of the authors appears to have reviewed for another journal.
The publisher and editors-in-chief of the Journal of Food Process Engineering became aware of the breach when the author of the unpublished manuscript lodged a complaint that his paper, under review at another journal, had been plagiarized by the now retracted paper.
We’re hazy on a few details in this case. Although the journal editor told us the “main author” of the retracted paper reviewed the original manuscript for another journal, the corresponding author of the retracted paper said he was not to blame. (More on that below.)
When looking into the matter, the publisher found that one of the co-authors of the published paper had acted as a reviewer of the unpublished manuscript. Alexandra Cury, an associate editor at Wiley, explained: Read the rest of this entry »
Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.
Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.
The latest batch of retractions stem from the actions of Jagadeesh Rao.
Here’s the first notice, issued by Psychopharmacology:
The author of a 2016 paper has agreed to retract it after an investigation revealed that most of the article came from another research group at the same university.
According to the notice, the author based the majority of his paper on results generated by other scientists without their permission.
Here’s the retraction notice for “Controlled synthesis of magnetic block copolymers for anti-microbial purpose,” published in the Journal of Applied Polymer Science in November and retracted in February: Read the rest of this entry »
A psychoanalyst has retracted an award-winning 2016 paper over concerns that it contained “sensitive” patient information.
On July 15, Judith L. Mitrani, a psychoanalyst based in California, published an article that included “sensitive clinical material” about a patient. Although we do not know what prompted the concerns, on November 21, Mitrani, in agreement with the journal’s editor-in-chief and publisher, retracted the article. The author and editor told us the retraction was meant to prevent non-experts from accessing the paper and to stop other non-Wiley sites from posting it.
The article was published after it had won the journal’s essay contest in 2015.
Here’s the retraction notice for “On Separating One from the Other: Images of a Developing Self,” published in the British Journal of Psychotherapy (BJP):
An oncology journal has retracted a 2014 paper that contained a potentially fatal mistake.
Specifically, the paper suggested that a chemotherapy drug be injected intrathecally — i.e., in the spine. But according to the retraction notice, the medical literature has unequivocally shown that that form of treatment is “uniformly fatal.”
The retraction comes approximately 18 months after the journal published a letter to the editor alerting readers to the risky wording in the 2014 paper.
Here’s the notice, issued by Hematological Oncology:
Sometime in the middle of 2015, Jennifer Byrne, professor of molecular oncology at the University of Sydney, began her journey from cancer researcher to a scientific literature sleuth, seeking out potentially problematic papers.
The first step was when she noticed several papers that contained a mistake in a DNA construct which, she believed, meant the papers were not testing the gene in question, associated with multiple cancer types. She started a writing campaign to the journal editors and researchers, with mixed success. But less than two years later, two of the five papers she flagged have already been retracted.
When asked why she spent time away from bench research to examine this issue, Byrne told us: Read the rest of this entry »
Researchers have agreed to pull a 2015 study exploring whether a plant extract can safeguard tanners from ultraviolet exposure after not obtaining formal approval from an ethics committee.
According to the first author, the problem lay in a misunderstanding – when they originally applied for approval six years ago, the researchers believed they didn’t need to go through a formal approval process, since the compound was commercially available without a prescription. Once they realized their mistake, they chose to retract the paper.
Here’s the retraction note for “Oral Polypodium leucomotos increases the anti-inflammatory and melanogenic responses of the skin to different modalities of sun exposures: a pilot study,” published in Photodermatology Photoimmunology & Photomedicine. Read the rest of this entry »
On December 31st 2014, a pioneer in the study of inflammatory bowel disease passed away. An obituary published in the Journal of Digestive Diseases shortly thereafter is typical enough: It describes his achievements, importance to his patients, and battle with pancreatic cancer.
But “Loss in the Last Day of 2014: a Eulogy for Prof. Bing Xia” has now been retracted.
This is the first time we’ve seen an obituary pulled from a journal. Unfortunately, this was not a case of a premature obituary (which happens more often than you’d think)– the researcher did actually die, but it appears the journal published the obituary in the wrong place.
The retraction notice, published earlier this year, explains:
According to the retraction notice in Advanced Materials, Mehdi Ghaffari — formerly based at Penn State — was solely responsible for the misconduct. Ghaffari’s LinkedIn page says he finished his PhD at Penn State in 2014, and now works as an independent consultant in New York, after a stint as a postdoc at Procter and Gamble.
A Penn State spokesperson sent us this statement: Read the rest of this entry »
A bone researcher based in Japan with 10 retractions under his belt has retracted two more papers for similar reasons — problems with the underlying data, and including co-authors who didn’t participate in the project.